Patent Assignment
Reel/Frame 060711/0374
Assignment of Assignor's Interest
Recorded: 2022-08-03
Pages: 6
Assignor
GLORIANA THERAPEUTICS, INC.
Executed: 2022-04-22
Assignee
SINFONIA BIOTHERAPEUTICS AB
HALSOVAGEN 7, 14157 HUDDINGE, STOCKHOLM, SWEDEN
Covered Properties
(8)
Polymer-Conjugated Glycosylated Neublastin
Neublastin Expression Constructs
Methods of Activating Ret Receptor Tyrosine Kinase Using Neurotrophic Factors
Methods for Increasing Vascularization
Polymer-Conjugated Glycosylated Neublastin
Anti-Neublastin Antibodies and Uses Thereof
Mammalian Cell Culture-Produced Neublastin Antibodies
Selective Agonist Of Alpha6 Containing nAChRs
Application:
17/108,881 →
Publication:
US 2022/0143014
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 31, 2011
From: ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 025719/0689 →
Assignment of Assignor's Interest
May 9, 2011
From: SILVESTRE, JEAN-SEBASTIEN; TAMARAT, RADIA
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 026245/0128 →
Assignment of Assignor's Interest
Jun 17, 2013
From: SAH, DINAH WEN-YEE; PEPINSKY, R. BLAKE; ROSSOMANDO, ANTHONY
To: BIOGEN IDEC MA INC.
Reel/Frame 030624/0899 →
Assignment of Assignor's Interest
Jan 8, 2015
From: ROSSOMANDO, ANTHONY; JIN, PING
To: BIOGEN IDEC MA INC.
Reel/Frame 034668/0043 →
Change of Name
May 4, 2015
From: BIOGEN IDEC MA INC.
To: BIOGEN MA INC.
Reel/Frame 035571/0926 →
Assignment of Assignor's Interest
Apr 6, 2017
From: BIOGEN MA INC.
To: GLORIANA THERAPEUTICS SARL
Reel/Frame 041887/0117 →
Assignment of Assignor's Interest
Apr 26, 2019
From: GLORIANA THERAPEUTICS SARL
To: GLORIANA THERAPEUTICS, INC.
Reel/Frame 049005/0877 →
Assignment of Assignor's Interest
Jan 5, 2023
From: GLORIANA THERAPEUTICS
To: SINFONIA BIOTHERAPEUTICS AB
Reel/Frame 062287/0670 →